Posts tagged ‘science’
Today on Pharma Strategy Blog, Sally Church comments on the sheer volume of data associated with modern science, a topic considered by Science magazine in their February 11, 2011 issue.
What makes this close to our heart at Icarus Consultants, is that what we do for a living as a marketing strategy company focusing on the life sciences, pharmaceutical and biotechnology industries, is process a lot of data. Anybody can provide you with a data dump of all the posters or presentations from a scientific meeting, but what does this data mean, what do the key opinion leaders think and what are the strategic implications that come out of it?
In the internet era, the amount of data available to us is increasing, but we are faced by more demands on our time. That’s why people often hire us, not to do what they cannot do themselves, but what they don’t have the time to do. It takes time to process data and generate analysis and insight.
More perspective on this topic can be found on Pharma Strategy Blog.
Sally Church, PhD will be attending the 6th International Society of Gastroenterological Carcinogenesis (ISGC) meeting in Houston from Thursday 6th to Saturday, 8th January, 2011. Hosted by the MD Anderson Cancer Center, the meeting has an impressive line up of key opinion leaders. Further information can be found on the Pharma Strategy Blog.
Published by Sally Church on Pharma Strategy Blog
Published by Pieter Droppert on Biotech Strategy Blog
Published by Sally Church on Pharma Strategy Blog
Published by Pieter Droppert on Biotech Strategy Blog
Nuclear Receptor expression defines a set of prognostic biomarkers for lung cancer
December 20th, 2010
Daedalus
Published by Sally Church on Pharma Strategy Blog
Published by Sally Church on Pharma Strategy Blog
Published by Sally Church on Pharma Strategy Blog
